Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

Online trolls had recently suggested that Kellie was lying about her diagnosis, comparing her to notorious 'cancer faker' ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...

Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...

A mum who ran the London Marathon with a stoma bag and raised more than £10,000 for charity said it was "one of the best days ...

In patients of Lynch syndrome -- an inherited condition -- risk of developing a second tumour could be lower among those having an extended resection, involving a removal of organs and tissues ...

Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...

The 35-year-old left-hander always flashes back to losing his dad to colon cancer at the start of his sophomore year at his ...

Yankees reliever Tim Hill, winter brings anxiety. Every year, his blood tests and colonoscopy revive painful memories of losing his father to colon cancer and ...